Details for 2015778162

Up to date per 03.04.2026

Actions

Title / Product Name

KRISTALLINE FORM VON 1-(1-METHYL-1H-PYRAZOL-4-YL)-N-((1R,5S,7S)-9-METHYL-3-OXA-9-AZABICYCLO[3.3.1]NONAN-7-YL)-1H-INDOL-3-CARBOXAMID

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2015778162

EP Publication Number

3201203

E-Number

1393865

Language

PCT Number

US15052806

Publication Date

09.08.2017 A

19.05.2021 B1

Registration Date

19.05.2021

AT Publication Date

15.06.2021

Application Date

29.09.2015

Registration Number

Priorities

29.09.2014

201462056982 P

IPC

C07D 498/08 20060101AFI20160415BHEP

Maximum Duration of Protection

29.09.2035

Owner

Takeda Pharmaceutical Company Limited1-1 Doshomachi 4-chome Chuo-ku Osaka-shi, Osaka 541-0045JP

Representative

No representatives present

Inventor

ZHAO, Yuxinc/o Takeda California Inc. 10410 Science Center Drive San Diego, California 92121US

Information about Fees